NCT05030025 Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) Status COMPLETED Phase EARLY_PHASE1
NCT05004038 BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: Status COMPLETED Phase PHASE2
NCT04985890 A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir Status NOT_YET_RECRUITING Phase PHASE2
NCT04979468 Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study) Status UNKNOWN Phase PHASE3
NCT04965662 The Role of Home Packs of HIV PEPSE in High Risk Individuals Status COMPLETED Phase PHASE4
NCT04963712 Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder Status COMPLETED Phase EARLY_PHASE1
NCT04950530 The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04897737 Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP Status COMPLETED Phase NA
NCT04892654 Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch Status RECRUITING Phase PHASE3
NCT04888754 A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04884139 DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: Status COMPLETED Phase PHASE4
NCT04883255 Cannabis Use, Cognition, and the Endocannabinoid System in HIV Status RECRUITING Phase EARLY_PHASE1
NCT04880395 Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 Status COMPLETED Phase PHASE4
NCT04860063 Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. Status UNKNOWN Phase PHASE3
NCT04770701 Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes Status COMPLETED Phase PHASE4
NCT04738812 Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression Status COMPLETED Phase PHASE3